142 related articles for article (PubMed ID: 7541997)
21. Fetal fibronectin as predictor of successful induction of mid-trimester abortion.
Mercorio F; Mercorio A; Votino C; Di Spiezio Sardo A; Barba GV; Nappi C
Acta Obstet Gynecol Scand; 2005 Apr; 84(4):390-4. PubMed ID: 15762972
[TBL] [Abstract][Full Text] [Related]
22. [Screening for adverse perinatal outcome by biomarkers in maternal serum; a comparison of elevated maternal serum alpha-fetoprotein versus human chorionic gonadotropin].
Tanaka M; Natori M; Ishimoto H; Gohda N; Kiyokawa K; Yamauchi J; Miyazaki T; Kobayashi T; Nozawa S
Nihon Sanka Fujinka Gakkai Zasshi; 1994 Nov; 46(11):1229-33. PubMed ID: 7531210
[TBL] [Abstract][Full Text] [Related]
23. Interleukin-8 and glucose in amniotic fluid, fetal fibronectin in vaginal secretions and preterm labor index based on clinical variables are optimal predictive markers for preterm delivery in patients with intact membranes.
Yoneda S; Sakai M; Sasaki Y; Shiozaki A; Hidaka T; Saito S
J Obstet Gynaecol Res; 2007 Feb; 33(1):38-44. PubMed ID: 17212664
[TBL] [Abstract][Full Text] [Related]
24. Outcome in infants born to mothers with unexplained elevations of maternal serum alpha-fetoprotein.
Burton BK; Dillard RG
Pediatrics; 1986 Apr; 77(4):582-6. PubMed ID: 2421232
[TBL] [Abstract][Full Text] [Related]
25. Pregnancy outcome in women with low midtrimester maternal serum unconjugated estriol.
Santolaya-Forgas J; Jessup J; Burd LI; Prins GS; Burton BK
J Reprod Med; 1996 Feb; 41(2):87-90. PubMed ID: 8656420
[TBL] [Abstract][Full Text] [Related]
26. Quad screen as a predictor of adverse pregnancy outcome.
Dugoff L; Hobbins JC; Malone FD; Vidaver J; Sullivan L; Canick JA; Lambert-Messerlian GM; Porter TF; Luthy DA; Comstock CH; Saade G; Eddleman K; Merkatz IR; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; D'Alton ME;
Obstet Gynecol; 2005 Aug; 106(2):260-7. PubMed ID: 16055573
[TBL] [Abstract][Full Text] [Related]
27. Sensitivity and specificity of screening for Down syndrome with alpha-fetoprotein, hCG, unconjugated estriol, and maternal age.
MacDonald ML; Wagner RM; Slotnick RN
Obstet Gynecol; 1991 Jan; 77(1):63-8. PubMed ID: 1701526
[TBL] [Abstract][Full Text] [Related]
28. Prognostic significance of unexplained elevated amniotic fluid alpha-fetoprotein.
Wenstrom KD; Owen J; Davis RO; Brumfield CG
Obstet Gynecol; 1996 Feb; 87(2):213-6. PubMed ID: 8559526
[TBL] [Abstract][Full Text] [Related]
29. Second-trimester maternal serum alpha-fetoprotein, human chorionic gonadotropin, and unconjugated oestriol after early transvaginal multifetal pregnancy reduction.
Groutz A; Amit A; Yaron Y; Yovel I; Wolman I; Legum C; Lessing JB
Prenat Diagn; 1996 Aug; 16(8):723-7. PubMed ID: 8878282
[TBL] [Abstract][Full Text] [Related]
30. Elevated second-trimester maternal serum hCG alone or in combination with elevated alpha-fetoprotein.
Benn PA; Horne D; Briganti S; Rodis JF; Clive JM
Obstet Gynecol; 1996 Feb; 87(2):217-22. PubMed ID: 8559527
[TBL] [Abstract][Full Text] [Related]
31. Maternal serum ferritin concentration in patients with preterm labor and intact membranes.
Weintraub AY; Sheiner E; Mazor M; Levy A; Tevet A; Paamoni O; Wiznitzer A
J Matern Fetal Neonatal Med; 2005 Sep; 18(3):163-6. PubMed ID: 16272038
[TBL] [Abstract][Full Text] [Related]
32. Extremely high maternal serum alpha-fetoprotein levels at second-trimester screening.
Killam WP; Miller RC; Seeds JW
Obstet Gynecol; 1991 Aug; 78(2):257-61. PubMed ID: 1712441
[TBL] [Abstract][Full Text] [Related]
33. Abnormal levels of maternal serum human chorionic gonadotropin and alpha-fetoprotein in the second trimester: relation to fetal weight and preterm delivery.
Morssink LP; Kornman LH; Beekhuis JR; De Wolf BT; Mantingh A
Prenat Diagn; 1995 Nov; 15(11):1041-6. PubMed ID: 8606883
[TBL] [Abstract][Full Text] [Related]
34. Hyaluronan (HA) and serum-derived hyaluronan-associated protein (SHAP)-HA complex as predictive markers of cervical ripening in premature labor.
Kishida T; Yabushita H; Wakatsuki A; Zhuo L; Kimata K
Connect Tissue Res; 2008; 49(2):105-8. PubMed ID: 18382897
[TBL] [Abstract][Full Text] [Related]
35. Second-trimester amniotic fluid or maternal serum interleukin-10 levels and small for gestational age neonates.
Spong CY; Sherer DM; Ghidini A; Jenkins CB; Seydel FD; Eglinton GS
Obstet Gynecol; 1996 Jul; 88(1):24-8. PubMed ID: 8684756
[TBL] [Abstract][Full Text] [Related]
36. Elevated maternal serum alpha-fetoprotein with low unconjugated estriol and the risk for lethal perinatal outcome.
Benn PA; Craffey A; Horne D; Ramsdell L; Rodis JF
J Matern Fetal Med; 2000; 9(3):165-9. PubMed ID: 10914624
[TBL] [Abstract][Full Text] [Related]
37. A prospective evaluation of a second-trimester screening test for fetal Down syndrome using maternal serum alpha-fetoprotein, hCG, and unconjugated estriol.
Cheng EY; Luthy DA; Zebelman AM; Williams MA; Lieppman RE; Hickok DE
Obstet Gynecol; 1993 Jan; 81(1):72-7. PubMed ID: 7677967
[TBL] [Abstract][Full Text] [Related]
38. Mid-pregnancy maternal plasma levels of interleukin 2, 6, and 12, tumor necrosis factor-alpha, interferon-gamma, and granulocyte-macrophage colony-stimulating factor and spontaneous preterm delivery.
Curry AE; Vogel I; Drews C; Schendel D; Skogstrand K; Flanders WD; Hougaard D; Olsen J; Thorsen P
Acta Obstet Gynecol Scand; 2007; 86(9):1103-10. PubMed ID: 17712652
[TBL] [Abstract][Full Text] [Related]
39. [Unexplained increase in maternal plasma in alpha-fetoproteins in the second trimester of pregnancy: perinatal results].
Cox M U; Kingdom J; Whittle M; McNay M; Fleming J; Bowman A; Crossley J; Aitken D
Rev Chil Obstet Ginecol; 1995; 60(3):174-80. PubMed ID: 8728745
[TBL] [Abstract][Full Text] [Related]
40. Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: a prospective investigation.
Wadhwa PD; Garite TJ; Porto M; Glynn L; Chicz-DeMet A; Dunkel-Schetter C; Sandman CA
Am J Obstet Gynecol; 2004 Oct; 191(4):1063-9. PubMed ID: 15507922
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
